This contract expires in 111 days (Sep 30, 2026).

Browse related active opportunities

FIRM FIXED PRICE

MCKESSON CORPORATION - FY26 MCKESSON MEDICATION 1ST QTR OCTOBER-DECEMBER 2025

PIID: 15B12026F00000005
Signed Date: Jan 28, 2026Effective Date: Oct 1, 2025End Date: Closes in 111 days
Award $
$461K
Vendor
MCKESSON CORPORATION
NAICS
325412
Signed Date
Jan 28, 2026

Key Details

Dollars Obligated
$460,647.32
Base & All Options
$30,000
Awarding Agency
Department of Justice
Awarding Sub-Agency
Federal Prison System / Bureau of Prisons
Product Service Code
6505 - DRUGS AND BIOLOGICALS
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
IRVING, TX, 750392402, CD-TX-33

Description

FY26 MCKESSON MEDICATION 1ST QTR OCTOBER-DECEMBER 2025

Context & Analysis

On Jan 28, 2026, Department of Justice obligated $460,647.32 to MCKESSON CORPORATION for fy26 mckesson medication 1st qtr october-december 2025. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition. Performance is located in IRVING, TX. The contract is scheduled through Sep 30, 2026 — approximately 4 months remaining.

Contractor Information

UEI: S1RUKWWRYFL6
CAGE Code: 1MKG3
Location: IRVING, TX
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related